The Stem Cell Mobilizer
AFA (Aphanizomenon flos-aquae)
Clinically validated to:
- Increase circulating CD34+ stem cells, the same cells used in bone marrow transplants to regenerate organ systems
- Mobilize CD133+ progenitor cells, which support vascular repair and tissue regeneration throughout the body
- Modulate CXCR4 expression, the receptor that signals stem cells to leave bone marrow and enter circulation
- Activate Natural Killer cells, enhancing immune surveillance and cellular cleanup
Clinical Results:
- Significant increase in circulating stem cells documented within hours of consumption
- Both CD34+CD133+ and CD34+CD133- populations increased
University Research:
Jensen et al. published in Cardiovascular Revascularization Medicine demonstrated that AFA consumption mobilized human CD34+ and CD133+ stem cells in vivo. The study confirmed stem cell release was related to modulation of CXCR4 expression by an L-selectin ligand.
